TRAZIMERA

This brand name is authorized in Australia, Austria, Brazil, Canada, Croatia, Ecuador, Estonia, Finland, France, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Spain, Turkey, UK.

Active ingredients

The drug TRAZIMERA contains one active pharmaceutical ingredient (API):

1
UNII P188ANX8CK - TRASTUZUMAB
 

Trastuzumab is a recombinant humanised IgG1 monoclonal antibody against the human epidermal growth factor receptor 2 (HER2). Τrastuzumab has been shown, in both in vitro assays and in animals, to inhibit the proliferation of human tumour cells that overexpress HER2.

 
Read more about Trastuzumab

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
L01FD01 Trastuzumab L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01F Monoclonal antibodies and antibody drug conjugates → L01FD HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors
Discover more medicines within L01FD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 10383L, 10391X, 10401K, 10402L, 10581X, 10588G, 10589H, 10597R, 4632T, 4639E, 4650R, 4703M, 7264H, 7265J, 7266K, 7267L
BR Câmara de Regulação do Mercado de Medicamentos 522720040085207, 522720040085307
CA Health Products and Food Branch 02483467, 02483475
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 198-MBE-0521
EE Ravimiamet 1777260, 1800414
ES Centro de información online de medicamentos de la AEMPS 1181295001, 1181295002
FI Lääkealan turvallisuus- ja kehittämiskeskus 039145, 554131
FR Base de données publique des médicaments 64461946, 65913265
GB Medicines & Healthcare Products Regulatory Agency 367564, 376164
IL מִשְׂרַד הַבְּרִיאוּת 8750, 8751
IT Agenzia del Farmaco 046922011, 046922023
LT Valstybinė vaistų kontrolės tarnyba 1086088, 1088045
NL Z-Index G-Standaard, PRK 150975, 57991
NZ Medicines and Medical Devices Safety Authority 20813, 20814
PL Rejestru Produktów Leczniczych 100410172, 100422732
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W64935001, W66584001
TR İlaç ve Tıbbi Cihaz Kurumu 8681308791016

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.